Active, not recruitingNot applicableNCT00579514

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Kenneth Offit, MD
Memorial Sloan Kettering Cancer Center
Intervention
PCR/PCR/LDR Strategy(genetic)
Enrollment
21081 enrolled
Eligibility
All sexes
Timeline
20002027

Study locations (1)

Collaborators

Columbia University · Weill Medical College of Cornell University · Icahn School of Medicine at Mount Sinai

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00579514 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials